Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP-8203 + rtPA in Acute Ischemic Stroke
NCT04479449Phase 2Completed
- Sponsor
- Shinpoong Pharma
- Start
- Mar 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of otaplimastat in ischemic stroke, sponsored by Shinpoong Pharma. Started Mar 2019; status: completed.
02
Drugs
otaplimastat
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04479449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479449.